Heltra: Explore Life – Discover More – Live Better

Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts (NASDAQ:GNLX)

Bull and bear shape writing by lines and dots.

sutthirat sutthisumdang

Roth MKM started protection of Genelux (NASDAQ:GNLX) with a buy score, citing the corporate’s drug Olvi-Vec within the remedy of ovarian most cancers.

The funding agency stated that whereas it sees danger heading right into a pivotal readout in 2025, it believes regionally

Source: Seekingalpha

ADVERTISEMENT